SMITH JASON DREW

PrivateCIK: 1821479
Location

PRINCETON, NJ

SMITH JASON DREW (General Counsel) sold 5.3% of their position (414.00 shares) of UROGEN PHARMA LTD. on the open market

Open‑market sale worth $3.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderSMITH JASON DREWCIK 1821479
IssuerUROGEN PHARMA LTD.CIK 1668243
Officer· General Counsel
Since Aug 2020
+37.09K
Net shares
Net buyer
$3.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
38.33K acquired · 1.25K disposed
Non-Derivative Transactions2

Ordinary Shares

Direct
M · Option Exercise

Shares

+833.00

Price / share

Trade value

% of position

11.8%
1/31/2022
7.03K7.86K

Ordinary Shares

Direct
S · Sale

Shares

414.00

Price / share

$7.58

Trade value

$3.14K

% of position

5.3%
1/31/2022
7.86K7.45K
Total

Net shares

+419.00

Net value

-$3.14K

Derivative Transactions3

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Ordinary Shares

833.00 shares

Shares

833.00

Strike price

Held after

1.67K

Exercisable

1/31/2022

Restricted Stock Units

Direct
A · Award
Converts to

Ordinary Shares

7.50K shares

Shares

+7.50K

Strike price

Held after

7.50K

Exercisable

1/31/2022

Stock Option (right to buy)

Direct
A · Award
Converts to

Ordinary Shares

30K shares

Shares

+30K

Strike price

7.72

Held after

30K

Exercisable

1/31/2022
SMITH JASON DREW — Insider Transaction (Form 4) Filed Feb 2, 2022 | Finecho